24 results on '"DeAngelo, Daniel J"'
Search Results
2. Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.
3. A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia
4. Ponatinib after failure of second‐generation tyrosine kinase inhibitor in resistant chronic‐phase chronic myeloid leukemia
5. Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remission
6. Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission
7. De novo acute myeloid leukemia with 20–29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study
8. Pretreatment clinical and genetic factors predict early post‐treatment mortality in fit AML patients following induction
9. An extreme example of focal bone marrow involvement in acute myeloid leukemia
10. Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITD
11. An asymptomatic 61-year-old man with BCR-ABL-positive bone marrow following autologous transplantation for multiple myeloma
12. Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission
13. Clinical JAK2 V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations
14. Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re‐induction chemotherapy
15. Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin
16. Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re‐induction chemotherapy.
17. Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results
18. Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens
19. A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia
20. De novoacute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study
21. An extreme example of focal bone marrow involvement in acute myeloid leukemia
22. Invasive fungal disease in patients treated for newly diagnosed acute leukemia
23. ClinicalJAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations
24. Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.